December 15, 2021
Empowering customer-facing teams to nurture meaningful HCP engagement
Empowering customer-facing teams to nurture meaningful HCP engagement
Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software.
“The COVID-19 pandemic drove new imperatives to realize the power of data and technologies such as digital and virtual engagement that had been sitting at the peripheries for years.
Support for hybrid engagement strategy is a must in the post pandemic normal”
A modern front-end optimized for field teams to reach more customers, personalize each interaction, and capture more insights.
The last-mile of your NBA engine to deliver the right insight at the right time, with greater actionability and closed loop learning.
A cross-channel communication platform for hybrid warriors to engage customers how they prefer.
A secure, WhatsApp-like channel for customers to connect with your team, content and community more frequently and on their time.
A modern front-end optimized for field teams to reach more customers, personalize each interaction, and capture more insights.
The last-mile of your NBA engine to deliver the right insight at the right time, with greater actionability and closed loop learning.
A cross-channel communication platform for hybrid warriors to engage customers how they prefer.
A secure, WhatsApp-like channel for customers to connect with your team, content and community more frequently and on their time.
Tact.ai, the customer engagement company for life sciences, today announced a new round of equity financing totaling $33 million that included investments from Novartis (dRx Capital), Lilly and McKesson Ventures. Existing investors including Microsoft’s M12 and Salesforce Ventures also participated in the round, bringing the company’s total funding to $88 million.
Empowering customer-facing teams to nurture meaningful HCP engagement
Gaurav Sharma, Vice President, Vertical Products at Tact.ai on Omnichannel HCP engagement and how pharma teams need adopt to on-demand engagement
A must read definitive guide to understanding evolution of HCP engagement post COVID-19
"As healthcare organizations prioritize interactions that improve patient outcomes, the opportunity to bring to market a next generation engagement platform for biopharma has emerged, Tact.ai supports our thesis that commercial strategies for biopharma should account for both field force and prescriber needs, ensuring the right data is leveraged at the right time to enable the best decisions and support for patients."
"Our Commercial and Medical teams at Novartis have been collaborating with Tact over the last two years to transform our field force and customer experience globally. Tact.ai aligns with our ambition to reimagine customer engagement for the New Normal."
Sales Performance Management 2021
AI 100 Ranking 2021 - Sales and CRM
Life Science Commercial Operations 2021
CRM Sales Technology 2021
Top Sales Productivity Solutions
